Retinol palmitate clinical trials
Also written Vitamin A palmitate.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses retinol palmitate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 28 Jul 1947 · BEROCCA PN · NDA 006071 (FDA, Drugs@FDA; in a combination)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 8
National Eye Institute (NEI) (2) · Assiut University (1) · Children's Hospital of Philadelphia (1) · USDA, Western Human Nutrition Research Center (1) · Universidade Federal do Rio de Janeiro (1) · London School of Hygiene and Tropical Medicine (1) · Duke University (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
Studies
Open first, then newest update. How each study uses retinol palmitate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark AdaptationCompletedEarly Phase 1National Eye Institute (NEI)NCT03478878Written as Vitamin A Palmitate
- Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark AdaptationCompletedEarly Phase 1National Eye Institute (NEI)NCT03478865Written as Vitamin A palmitate
- The Dark-Adapted Retinal Function Response in Choroideremia (DARC) StudyWithdrawnNot applicableDuke UniversityNCT05045703Written as Vitamin A palmitate
- Retinyl Palmitate-loaded Ethosomes in Acne VulgarisCompletedPhase 2Assiut UniversityNCT04080869Written as retinyl palmitate
- Nutritional Outcomes After Vitamin A Supplementation in Subjects With SCDCompletedNot applicableChildren's Hospital of PhiladelphiaNCT03632876Written as retinyl palmitate
- Efficacy of Newborn Vitamin A Supplementation in Improving Immune FunctionCompletedNot applicableUSDA, Western Human Nutrition Research CenterNCT01583972Written as retinyl palmitate
- Effect of Vitamin A Supplementation on Immune Responses in Human NeonatesStatus unknownPhase 2London School of Hygiene and Tropical MedicineNCT01476358Written as Vitamin A (retinyl palmitate).
- Relative-dose-response Test (RDR) Adaptation for Chronic Liver DiseaseCompletedNot applicableUniversidade Federal do Rio de JaneiroNCT01634698Written as retinyl palmitate (UNICEF, Melbourne, Australia)
As the comparator · 1 — what is tested is compared with retinol palmitate
Codes
What other systems call retinol palmitate · ClinicalTrials.gg INT002608
- MeSH (NLM) C014794retinol palmitateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 1D1K0N0VVCVITAMIN A PALMITATEConfirmed FDA, NLM
- RxNorm 35406One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C014794 | retinol palmitate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 1D1K0N0VVC | VITAMIN A PALMITATE | Confirmed FDA, NLM |
| RxNorm | 35406 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.